Cisplatin

RB transcriptional corepressor 1 ; Homo sapiens







20 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35506019 Deconstructing ADAURA: It is Time to Forgo Adjuvant Platinum-Based Chemotherapy in Resected IB-IIIA EGFR+ NSCLC (Except with RB Alterations?) When Adopting Adjuvant Osimertinib. 2022 1
2 34873472 CDKN1A/p21WAF1, RB1, ARID1A, FLG, and HRNR mutation patterns provide insights into urinary tract environmental exposure carcinogenesis and potential treatment strategies. 2021 1
3 32165095 Defects in DNA Repair Genes Confer Improved Long-term Survival after Cisplatin-based Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer. 2020 Aug 2
4 32173903 Hypoxia-induced lncRNA ANRIL promotes cisplatin resistance in retinoblastoma cells through regulating ABCG2 expression. 2020 Jun 2
5 32229099 Ribociclib mitigates cisplatin-associated kidney injury through retinoblastoma-1 dependent mechanisms. 2020 Jul 2
6 30466007 Herb-drug interaction: A case study of effects and involved mechanisms of cisplatin on the pharmacokinetics of ginsenoside Rb1 in tumor-bearing mice. 2019 Feb 1
7 28403784 Synthesis, Characterization of 4-Anilino-6,7-Dimethoxy Quinazoline Derivatives as Potential Anti-Angiogenic Agents. 2018 Feb 7 1
8 29682192 ATM/RB1 mutations predict shorter overall survival in urothelial cancer. 2018 Mar 30 1
9 27825116 Ginsenoside-Rb1 targets chemotherapy-resistant ovarian cancer stem cells via simultaneous inhibition of Wnt/β-catenin signaling and epithelial-to-mesenchymal transition. 2017 Apr 18 1
10 28734226 Inhibition of pRB Pathway Differentially Modulates Apoptosis in Esophageal Cancer Cells. 2017 Oct 3
11 26238431 Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer. 2015 Dec 1
12 23521104 Bioresorbable polymersomes for targeted delivery of cisplatin. 2013 Apr 17 3
13 24085287 Anti-apoptotic effect of clusterin on cisplatin-induced cell death of retinoblastoma cells. 2013 Dec 1
14 22759219 The treatment of retinoblastoma with four-drug regimen including cisplatin, etoposide, vincristine, and cyclophosphamide. 2012 Sep 1
15 20428827 miRNA-regulated expression of oncogenes and tumor suppressor genes in the cisplatin-inhibited growth of K562 cells. 2010 Jun 2
16 19550397 Molecular profile and cell cycle in MCF-7 cells resistant to cisplatin and doxorubicin. 2009 Jun 1
17 16799811 Cisplatin's tumoricidal effect on human breast carcinoma MCF-7 cells was not attenuated by American ginseng. 2007 Feb 1
18 17351393 G1 arrest induction represents a critical determinant for cisplatin cytotoxicity in G1 checkpoint-retaining human cancers. 2007 Apr 2
19 16413407 S-phase arrest by reactive nitrogen species is bypassed by okadaic acid, an inhibitor of protein phosphatases PP1/PP2A. 2006 Jan 15 1
20 15492778 Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer (Review). 2004 Nov 2